Skip to content
Persephone Biosciences logo

Persephone Biosciences

Persephone Biosciences is a YC Winter 2018 (W18) company. Based in San Diego, CA, USA. Team of 6.

  • AI-powered Drug Discovery
  • COVID-19

About Persephone Biosciences

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Persephone Biosciences develops live biotherapeutic products targeting the gut microbiome, with a current focus on infant and toddler synbiotics. Its probiotic-prebiotic supplements replenish Bifidobacterium strains that are absent in the majority of babies today, replacing the guesswork of generic infant probiotics with clinically studied, strain-specific formulations validated in a randomized controlled trial.

Business model

Subscription purchase with promotional discounts for new customers

Go-to-market

Parents of infants and toddlers buy directly through the company's e-commerce store; healthcare practitioners are also addressed as a channel.

From the Y Combinator listing

How Persephone Biosciences describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

We are using the gut microbiome to end cancer.

Persephone Biome develops live biotherapeutic products to modulate the metabolism of gut microbes, for applications in disease prevention and cure. We take a unique engineering approach using systems and synthetic biology to understand the complexities of the microbiome.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
San Diego, CA, USA
Team size
6
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works